↓ Skip to main content

Complement Therapeutics

Overview of attention for book
Cover of 'Complement Therapeutics'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Progress and Trends in Complement Therapeutics
  3. Altmetric Badge
    Chapter 2 Inhibition of the Serine Proteases of the Complement System
  4. Altmetric Badge
    Chapter 3 The Role of MASP-1/3 in Complement Activation
  5. Altmetric Badge
    Chapter 4 Membrane-Bound Complement Regulatory Proteins as Biomarkers and Potential Therapeutic Targets for SLE
  6. Altmetric Badge
    Chapter 5 DAF as a Therapeutic Target for Steroid Hormones: Implications for Host–Pathogen Interactions
  7. Altmetric Badge
    Chapter 6 Targeting gC1qR Domains for Therapy Against Infection and Inflammation.
  8. Altmetric Badge
    Chapter 7 The Alternative C5a Receptor Function
  9. Altmetric Badge
    Chapter 8 The Effects of Selective Complement and CD14 Inhibition on the E. coli -Induced Tissue Factor mRNA Upregulation, Monocyte Tissue Factor Expression, and Tissue Factor Functional Activity in Human Whole Blood
  10. Altmetric Badge
    Chapter 9 CR2-Mediated Targeting of Complement Inhibitors: Bench-to-Bedside Using a Novel Strategy for Site-Specific Complement Modulation
  11. Altmetric Badge
    Chapter 10 Paroxysmal Nocturnal Hemoglobinuria and the Complement System: Recent Insights and Novel Anticomplement Strategies
  12. Altmetric Badge
    Chapter 11 Defective Complement Action and Control Defines Disease Pathology for Retinal and Renal Disorders and Provides a Basis for New Therapeutic Approaches
  13. Altmetric Badge
    Chapter 12 C3 Glomerulonephritis/CFHR5 Nephropathy Is an Endemic Disease in Cyprus: Clinical and Molecular Findings in 21 Families
  14. Altmetric Badge
    Chapter 13 Complement-Targeted Therapeutics in Periodontitis
  15. Altmetric Badge
    Chapter 14 Complement System Activation in Cardiac and Skeletal Muscle Pathology: Friend or Foe?
  16. Altmetric Badge
    Chapter 15 Innate Immunity as Orchestrator of Bone Marrow Homing for Hematopoietic Stem/Progenitor Cells
  17. Altmetric Badge
    Chapter 16 Complement-Mediated Microvascular Injury Leads to Chronic Rejection
  18. Altmetric Badge
    Chapter 17 Targeting Complement at the Time of Transplantation
  19. Altmetric Badge
    Chapter 18 Evaluation of the Blood Compatibility of Materials, Cells, and Tissues: Basic Concepts, Test Models, and Practical Guidelines
  20. Altmetric Badge
    Chapter 19 Noninvasive Detection of Complement Activation Through Radiologic Imaging
  21. Altmetric Badge
    Chapter 20 Complement Therapeutics
  22. Altmetric Badge
    Chapter 21 Complement in Action: An Analysis of Patent Trends from 1976 Through 2011
Attention for Chapter 2: Inhibition of the Serine Proteases of the Complement System
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Inhibition of the Serine Proteases of the Complement System
Chapter number 2
Book title
Complement Therapeutics
Published in
Advances in experimental medicine and biology, January 2013
DOI 10.1007/978-1-4614-4118-2_2
Pubmed ID
Book ISBNs
978-1-4614-4117-5, 978-1-4614-4118-2
Authors

Péter Gál, József Dobó, László Beinrohr, Gábor Pál, Péter Závodszky, Gál, Péter, Dobó, József, Beinrohr, László, Pál, Gábor, Závodszky, Péter

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 3%
Unknown 32 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 18%
Student > Bachelor 5 15%
Student > Ph. D. Student 5 15%
Student > Doctoral Student 3 9%
Student > Master 3 9%
Other 5 15%
Unknown 6 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 7 21%
Biochemistry, Genetics and Molecular Biology 5 15%
Medicine and Dentistry 4 12%
Immunology and Microbiology 3 9%
Chemistry 3 9%
Other 4 12%
Unknown 7 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2019.
All research outputs
#7,553,524
of 23,041,514 outputs
Outputs from Advances in experimental medicine and biology
#1,236
of 4,969 outputs
Outputs of similar age
#84,951
of 282,282 outputs
Outputs of similar age from Advances in experimental medicine and biology
#46
of 168 outputs
Altmetric has tracked 23,041,514 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,969 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,282 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 168 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.